CHC Solutions Revenue and Competitors

Claim your profile

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • CHC Solutions's estimated annual revenue is currently $31.6M per year.(i)
  • CHC Solutions's estimated revenue per employee is $251,000

Employee Data

  • CHC Solutions has 126 Employees.(i)
  • CHC Solutions grew their employee count by 37% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$52M2079%N/AN/A
#2
$2.8M270%N/AN/A
#3
$32.4M12912%N/AN/A
#4
$3.5M28-75%$64.3MN/A
#5
$10.3M418%N/AN/A
#6
$688.3M17141685%N/AN/A
#7
$39.2M15626%N/AN/A
#8
$18.1M7231%N/AN/A
#9
$18.6M740%N/AN/A
#10
$30.4M12119%N/AN/A

CHC Solutions, Inc. is a family of companies providing comprehensive medical supplies and equipment as well as patient-focused service. Our goal is to improve the patient experience and support individuals across the continuum of care. Family brands include Burmans Medical Supplies, bioCARE, Continuum and HealthSource. CHC Solutions provides options for wound care, urology and enteral/nutritional supplies as well as incontinence, orthopedics and ostomy products.

keywords:N/A

N/A

Total Funding

126

Number of Employees

$31.6M

Revenue (est)

37%

Employee Growth %

N/A

Valuation

N/A

Accelerator

CHC Solutions News

2022-04-20 - Cornwall Library presenting program on affordable housing

The CHC invests in affordable housing solutions by offering programs and services designed to develop, preserve, and sustain affordable...

2022-04-13 - CHC Navigation Introduces Airborne Lidar Series

CHC Navigation (CHCNAV) has released the AlphaAir 1400 (AA1400) and AlphaAir 2400 (AA2400) Lidar systems. Both solutions are compact...

2022-04-06 - CHC Navigation introduces AlphaAir 1400 and AlphaAir 2400 ...

CHCNAV provides a full range of solutions that allows a complete lidar solution to be added to the users' geomatic services.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.5M126N/AN/A
#2
$18.3M126-5%N/A
#3
$34M126-19%N/A
#4
$12.6M12616%N/A
#5
$28.1M12616%N/A